SPA100
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SPA100, covering 2012-06-13 to 2012-06-13. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension [Phase 3]